RLMD logo

Relmada Therapeutics (RLMD) Earnings Per Share

Annual EPS

-$3.28
+$2.02+38.11%

December 31, 2023


Summary


Performance

RLMD EPS Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRLMDprofitabilitymetrics:

Quarterly EPS

-$0.72
-$0.13-22.03%

September 30, 2024


Summary


Performance

RLMD Quarterly EPS Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRLMDprofitabilitymetrics:

TTM EPS

-$2.86
+$0.01+0.35%

September 30, 2024


Summary


Performance

RLMD TTM EPS Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRLMDprofitabilitymetrics:

EPS Formula

EPS =  
Net Income - Preferred Dividends
Shares Outstanding

RLMD EPS Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+38.1%0.0%+8.3%
3 y3 years+13.9%+70.5%+56.9%
5 y5 years-19.7%-89.5%-25.4%

RLMD EPS Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+54.2%-22.0%+60.0%at high+60.3%
5 y5-year-326.0%+54.2%-89.5%+70.5%-88.2%+60.3%
alltimeall time<-9999.0%+90.5%-126.1%+95.1%-158.6%+80.5%

Relmada Therapeutics EPS History

DateAnnualQuarterlyTTM
Sep 2024
-
-$0.72(+22.0%)
-$2.86(-0.3%)
Jun 2024
-
-$0.59(-18.1%)
-$2.87(-8.0%)
Mar 2024
-
-$0.72(-13.3%)
-$3.12(-4.6%)
Dec 2023
-$3.28(-38.1%)
-$0.83(+13.7%)
-$3.27(-11.6%)
Sep 2023
-
-$0.73(-13.1%)
-$3.70(-13.6%)
Jun 2023
-
-$0.84(-3.4%)
-$4.28(-10.3%)
Mar 2023
-
-$0.87(-31.0%)
-$4.77(-10.0%)
Dec 2022
-$5.30(-26.0%)
-$1.26(-3.8%)
-$5.30(-9.2%)
Sep 2022
-
-$1.31(-1.5%)
-$5.84(-16.2%)
Jun 2022
-
-$1.33(-5.0%)
-$6.97(-3.2%)
Mar 2022
-
-$1.40(-22.2%)
-$7.20(+0.8%)
Dec 2021
-$7.16(+87.9%)
-$1.80(-26.2%)
-$7.14(+7.7%)
Sep 2021
-
-$2.44(+56.4%)
-$6.63(+26.5%)
Jun 2021
-
-$1.56(+16.4%)
-$5.24(+18.8%)
Mar 2021
-
-$1.34(+3.9%)
-$4.41(+16.4%)
Dec 2020
-$3.81(+394.8%)
-$1.29(+22.9%)
-$3.79(+51.6%)
Sep 2020
-
-$1.05(+43.8%)
-$2.50(+36.6%)
Jun 2020
-
-$0.73(+1.4%)
-$1.83(+20.4%)
Mar 2020
-
-$0.72(+89.5%)
-$1.52(-33.3%)
Dec 2019
-$0.77(-71.9%)
-
-
Sep 2019
-
-$0.38(-9.5%)
-$2.28(-23.5%)
Jun 2019
-$2.74(-4.2%)
-$0.42(+16.7%)
-$2.98(-17.7%)
Mar 2019
-
-$0.36(-67.9%)
-$3.62(-15.8%)
Dec 2018
-
-$1.12(+3.7%)
-$4.30(+18.8%)
Sep 2018
-
-$1.08(+1.9%)
-$3.62(+26.6%)
DateAnnualQuarterlyTTM
Jun 2018
-$2.86(+37.5%)
-$1.06(+1.9%)
-$2.86(+23.3%)
Mar 2018
-
-$1.04(+136.4%)
-$2.32(+20.8%)
Dec 2017
-
-$0.44(+37.5%)
-$1.92(+4.3%)
Sep 2017
-
-$0.32(-38.5%)
-$1.84(-11.5%)
Jun 2017
-$2.08(+100.0%)
-$0.52(-18.8%)
-$2.08(-23.5%)
Mar 2017
-
-$0.64(+77.8%)
-$2.72(+1.5%)
Dec 2016
-
-$0.36(-35.7%)
-$2.68(-16.3%)
Sep 2016
-
-$0.56(-51.7%)
-$3.20(+166.7%)
Jun 2016
-$1.04(-87.6%)
-$1.16(+93.3%)
-$1.20(-144.1%)
Mar 2016
-
-$0.60(-31.8%)
$2.72(+13.3%)
Dec 2015
-
-$0.88(-161.1%)
$2.40(-50.8%)
Sep 2015
-
$1.44(-47.8%)
$4.88(-143.6%)
Jun 2015
-$8.36(-75.8%)
$2.76(-400.0%)
-$11.20(-19.8%)
Mar 2015
-
-$0.92(-157.5%)
-$13.96(+7.0%)
Dec 2014
-
$1.60(-110.9%)
-$13.04(-11.0%)
Sep 2014
-
-$14.64(>+9900.0%)
-$14.65(>+9900.0%)
Jun 2014
-$34.60(>+9900.0%)
-
-
Feb 2014
-
-$0.00(-78.2%)
-$0.03(-2.0%)
Nov 2013
-
-$0.01(+16.1%)
-$0.04(+12.0%)
Aug 2013
-$0.03(+271.8%)
-$0.01(-36.5%)
-$0.03(+9.0%)
May 2013
-
-$0.01(+372.4%)
-$0.03(+70.6%)
Feb 2013
-
-$0.00(-54.0%)
-$0.02(+17.2%)
Nov 2012
-
-$0.01(+3.3%)
-$0.01(+76.8%)
Aug 2012
-$0.01
-$0.01(+258.8%)
-$0.01(+290.5%)
May 2012
-
-$0.00(+325.0%)
-$0.00(+425.0%)
Feb 2012
-
-$0.00
-$0.00

FAQ

  • What is Relmada Therapeutics annual earnings per share?
  • What is the all time high annual EPS for Relmada Therapeutics?
  • What is Relmada Therapeutics annual EPS year-on-year change?
  • What is Relmada Therapeutics quarterly earnings per share?
  • What is the all time high quarterly EPS for Relmada Therapeutics?
  • What is Relmada Therapeutics quarterly EPS year-on-year change?
  • What is Relmada Therapeutics TTM earnings per share?
  • What is the all time high TTM EPS for Relmada Therapeutics?
  • What is Relmada Therapeutics TTM EPS year-on-year change?

What is Relmada Therapeutics annual earnings per share?

The current annual EPS of RLMD is -$3.28

What is the all time high annual EPS for Relmada Therapeutics?

Relmada Therapeutics all-time high annual earnings per share is -$0.01

What is Relmada Therapeutics annual EPS year-on-year change?

Over the past year, RLMD annual earnings per share has changed by +$2.02 (+38.11%)

What is Relmada Therapeutics quarterly earnings per share?

The current quarterly EPS of RLMD is -$0.72

What is the all time high quarterly EPS for Relmada Therapeutics?

Relmada Therapeutics all-time high quarterly earnings per share is $2.76

What is Relmada Therapeutics quarterly EPS year-on-year change?

Over the past year, RLMD quarterly earnings per share has changed by $0.00 (0.00%)

What is Relmada Therapeutics TTM earnings per share?

The current TTM EPS of RLMD is -$2.86

What is the all time high TTM EPS for Relmada Therapeutics?

Relmada Therapeutics all-time high TTM earnings per share is $4.88

What is Relmada Therapeutics TTM EPS year-on-year change?

Over the past year, RLMD TTM earnings per share has changed by +$0.26 (+8.33%)